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Summary  
 
Parkinson’s disease (PD) is the second most 
common neurodegenerative disease, affecting six 
million people worldwide. PD results from the 
specific loss of substantia nigra dopaminergic 
neurons. Aggregation of one protein, -synuclein, 
is characteristic of PD. This aggregation is thought 
to be a critical step in the etiology of the disease. 
While the molecular mechanism of -synuclein 
aggregation remains unknown, nitrative stress and 
phosphorylation have been implicated in -
synuclein modification and aggregation. In fact, 
nitration of -synuclein tyrosine residues 39, 125, 
133 or 136, may be an early event in aggregates, 
Lewy bodies, seen in PD. Furthermore, nitrative 
stress leads to the induction of -synuclein 
aggregation at a higher rate than seen in other PD 
mutants. This aggregation may result from a 
stabilization of pre-assembled -synuclein 
filaments, which, upon nitration, may withstand 
denaturing conditions and enhance formation of 
SDS-insoluble, heat-stable high mass aggregates. 
Phosphorylation of a-synuclein also appears to 
play a critical role in the formation of aggregates. 
Extensive studies indicate that -synuclein found in 
PD patient brains is extensively phosphorylated. 
Phosphorylation of ser-129 may enhance formation 
of aggregates reminiscent of Lewy bodies in vitro 
and in vivo. Nitration and phosphorylation of -
synuclein may be key to the mechanisms 
underlying the formation of Lewy bodies in PD. 
 
Introduction 
 
Parkinson’s disease (PD) is a common, fatal 
neurodegenerative disease that affects millions 
worldwide. This disease, characterized by postural 
instability, resting, and bradykinesia affects 1 in 50 
individuals over the age of 60 (Olanow and Tatton, 
1999; Periquet et al, 2007). There are two forms of PD: 
sporadic and familial. The sporadic form of PD is the 
most common, constituting ~90-95 of PD cases. The 
remaining 5-10% of PD cases are familial (Dauer et 
al.,2003). Although there is an increasing 
understanding of PD and its causes, there is still much 
to be investigated. Our knowledge is still very limited, 
and because of that, there is unfortunately still no cure 
for this tragic affliction. 
 
Pathology 
 
Both familial and sporadic forms of PD are linked to the 
death of midbrain dopaminergic substantia nigra 
neurons, which accumulate as misfolded and 
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aggregated protein -synuclein (Lee et al.,2004). As 
these cells die, there is diminished release of the 
neurotransmitter dopamine, which regulates the activity 
of parts of the brain that control movement initiation and 
coordination (Parkinson’s disease, 2007). This 
diminished amount of dopamine renders patients with a 
decreased ability to control and initiate movement, 
resulting in the clinical manifestations of PD.   
 Upon autopsy, neurons of the substantia 
nigra are found to contain large filamentous aggregates 
called Lewy bodies. The major component of Lewy 
bodies is a protein called -synuclein (Periquet et 
al.,2007).  
 
Characteristics of -Synuclein 
 
This natively unfolded protein of 140 amino acids has 
three major regions. The first major region of this 
protein is an N-terminal amphipathic region consisting 
of amino acids 1-61, while the central region consists of 
amino acids 61-95 (Periquet et al.,2007). Deletion of 
this region prevents -synuclein aggregation in vivo and 
in vitro, suggesting that this region is essential for 
aggregation of the protein (Periquet et al.,2007).   
Finally, the third region, a highly acidic C-terminal 
region consists of amino acids 95-140. This C-terminal 
region may have an inhibitory role in the aggregation of 
-synuclein, as C-terminally truncated forms of -
synuclein are found to aggregate into filaments more 
readily than full-length wild-type -synuclein (Periquet 
et al.,2007).   About 15% of Lewy bodies contain C-
terminally truncated -synuclein (Gaisson et al.,2000). 
This highly conserved protein of unknown 
function is found throughout the central nervous system 
and is abundant in neurons, especially in pre-synaptic 
terminals (Gaisson et al.,2000). As previously stated, 
the aggregation and misfolding of this protein 
contributes to the formation of Lewy bodies, which are 
hallmarks of the disease.  
Recent evidence has shed light on several 
post-translational events that can influence protein 
folding and function. This review will focus on the 
nitration and phosphorylation of -synuclein. An 
emphasis will be made on the affects of the previously 
mentioned post-translational modifications on -
synuclein and the link of these modifications on 
pathology of the disease.  
 
Phosphorylation of -synuclein 
 
Much research has gone into understanding the 
mechanism of Lewy Body formation and PD 
pathogenesis. While it is known that phosphorylation 
plays a key role in the functional properties of several 
proteins, there is limited knowledge on phosphorylation 
on PD-associated -synuclein (Okoshi et al.,2000)  
 Initially, specific post-translational 
modifications that underlie the aggregation of -
synuclein were not known. More recently, however, our 
knowledge has increased in regards to these post-
translational modifications due to several studies that 
have been conducted using a variety of models.   
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Figure 1. A) Effects of -synuclein phosphorylation : -synuclein is a natively soluble, unfolded protein characterized by the lack of 
rigid, well-defined three-dimensional structure. Pre-synaptic -synuclein aggregates to form Lewy bodies, the filamentous agrregates that 
characterize PD. Phosphorylated -synuclein have been found in Lewy bodies in PD patient brains. -synuclein is phosphorylated by 
casein kinase II at residue 125,  and is phosphorylated at residues  87 or 129. These post-translational modifications results in increased 
aggregation of -synuclein. 
B) Effects of -synuclein nitration: Nitrated -synuclein have been found in Lewy bodies in PD patient brains. a-synuclein is nitrated at 
residues  39, 125, 133, or 136. This post-translational modifications has been found to result in increased aggregation of -synuclein and 
may result in the presence of agrregates reminiscent of Lewy bodies. 
  
Phosphorylation of Serine and Tyrosine 
 
-synuclein is phosphorylated in vitro at several 
residues, including serines-87, and 129. These 
residues are phosphorylated by casein kinase 1 (CK-1) 
and casein kinase 2 (CK-2), but not by two other 
kinases, PKA or PKC (Okochi et al.,2000). 
Tyrosine residues are phosphorylated as 
well. A comparison of -synuclein family members 
reveals that all four tyrosine residues of -synuclein are 
conserved in all orthologs. This conservation suggests 
that these tyrosine residues may be of functional 
importance. In vitro analysis of -synuclein 
demonstrates that tyrosine phosphorylation occurs 
primarily on tyrosine 125 by Src protein-tyrosine kinase 
family members (Ellis et al., 2001). 
Using purified -synuclein from insoluble 
fraction of Lewy bodies, Fujiwara et al. established that 
Ser-129 of -synuclein is selectively and extensively 
phosphorylated in PD aggregates. Furthermore, 
phosphorylation of -synuclein promotes the formation 
of fibrils in vitro, establishing the importance of 
phosphorylation in the pathogenesis of Parkinson’s 
disease (Figure 1A.) (Fujiwara et al.,2002). Recent 
studies of Lewy bodies confirm Fujiwara’s findings that 
Ser-129 is extensively phosphorylated. This 
modification was found to be the dominant pathological 
modification of -synuclein in Lewy bodies (Anderson et 
al.,2006)  
 
-Synuclein or Synphilin-1?  
 
While many studies focus on -synuclein 
phosphorylation and its consequences, another study 
points to another protein’s phosphorylation as playing a 
critical role in aggregate formation.  
 
 
 
-Synuclein, along with the protein synphilin-
1, are found as components of Lewy bodies. The 
interaction between these two proteins is found to be 
phosphorylation dependent, as inhibition of CK-2, a 
kinase previously established to phosphorylate -
synuclein, results in an inhibition of binding of the two 
proteins. Furthermore, the inhibition of -synuclein and 
synphilin-1 binding results in a significant decrease in 
the percentage of cells that contain cytoplasmic 
aggregates (Lee et al.,2004). Interestingly, mutations in 
-synuclein that result in no -synuclein 
phosphorylation have no effect on -
synuclein/synphilin-1 interaction or aggregate 
formation. These results suggest that the interaction of 
these two proteins is phosphorylation dependent and 
that phosphorylation of synphilin-1, not -synuclein is 
critical for the formation of cytoplasmic aggregates (Lee 
et al., 2004). 
While one study implicates synphilin-1 
phosphorylation as key to aggregate formation, -
synuclein, the major component of Lewy bodies, is still 
of major interest and many studies still focus on this 
protein in an effort to understand the pathogenesis of 
PD. Using neuroblastoma cells, Smith and colleagues 
examined the effect of -synuclein phosphorylation on 
aggregate formation. Co-expression of mutant S129A 
of -synuclein, which abolishes phosphorylation and 
synphilin-1, results in few or no aggregates forming. 
Furthermore, co-immunoprecipitation assays reveal that 
there is a decreased interaction between -synuclein 
and synphilin-1. Together, these findings suggest that 
-synuclein phosphorylation is important for -
synuclein/synphilin interaction, as well as aggregate 
formation (Smith et al., 2005). 
Previous attempts at uncovering mechanisms 
for aggregate formation have been done in different 
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cells in vivo and in vitro. One study, however, uses a 
Drosophila model in order to examine the role of -
synuclein phosphorylation, specifically the 
phosphorylation of serine 129, on neurotoxicity and 
aggregate formation. When serine 129 is altered to a 
negatively charged residue, aspirate, mimicking 
phosphorylation, significant -synuclein toxicity is 
observed (Chen et al., 2005). Other studies, however, 
show that phosphorylation and nitrosylation-deficient 
mutants are toxic to yeast (Herrera et al., 2005). 
In vivo, -synuclein is phosphorylated by G-
protein receptor kinase (Gprk2). Moreover, blocking the 
phosphorylation of -synuclein results in a progressive 
accumulation of cytoplasmic aggregates resembling 
Lewy bodies (Chen et al., 2005).  
 
-synuclein Nitration 
 
Nitrative stress caused by oxidative injury has been 
implicated in the pathogenic mechanism of PD (Souza 
et al., 2000; Takahashi et al, 2002). Previous studies 
revealed the presence of nitrated proteins in several 
neurodegenerative disorders, and available evidence 
support the notion that -synuclein is a target for 
nitration (Souza et al., 2000; Gaisson et al.,2000). 
 
Nitration’s Link to Formation of Aggregates 
 
While it is known that -synuclein is nitrated in PD 
aggregates, the effects of this nitration remained to be 
elucidated (Duda et al.,2000). Initial studies focused on 
attempting to determine the effects of -synuclein 
nitration of the protein and its’ aggregation. Exposure of 
human recombinant -synuclein to nitrative and 
oxidative agents results in the formation of -synuclein 
aggregates (Souza et al., 2000; Paxinou et al., 2001). 
These aggregates are in the form of dimers, trimers and 
oligomers, suggesting cross-linking between nitrated 
tyrosine residues (Souza et al. 2000; Takahashi et al., 
2002.) 
To examine how concentration of nitrating 
agent affects the formation of aggregates, Souza and 
colleagues expose the cells to an increasing proportion 
of nitrating agent (Souza et al., 2000). Increasing the 
ratio of nitrating agent, such as peroxynitrtie/CO2, to 
protein not only results an increased nitration of dimers 
and trimers, but also in an augmentation in insoluble 
oligomers. Further examination of the protein reveals 
that it is nitrated at tyrosine 39, as well as tyrosine 125, 
133, and 136. Tyrosine-125, however, appears to have 
a critical role in -synuclein dimerization, as a lack of 
this residue significantly decreases dimerization 
compared to -synuclein lacking tyrosine 39, 133 or 
136 (Souza et al.,2000).  
 
Effects of Nitrative Stress 
  
Previous studies have established that nitrative and 
oxidative stress lead to the formation of aggregates in 
-synuclein transfected cells.  It has been hypothesized 
that tyrosine cross-linking may be the cause of this 
event. To test this hypothesis, Norris et al. mutated 
tyrosine residues and examined fibril formation in these 
mutant proteins. Results showed that one or more 
tyrosine residues are required for cross-linking resulting 
from the exposure to nitrating agents. Tyrosine residues 
are not required, however, for cross-linking resulting 
from the exposure to oxidative agents. Furthermore, the 
formation of aggregates after nitrative and oxidative 
stress in cells requires tyrosine residues (Norris et al., 
2003). 
Norris et al. propose a model to explain the 
role of nitration and oxidation in the formation of 
aggregates of -synuclein. It is proposed that soluble--
synuclein can be formed as a result of both nitration 
and oxidation. Nitration-induced oligomers and nitrated 
monomers, however, are incapable of assembling 
fibrils, the intermediate to aggregates. -synuclein 
monomers and oligomers that have been modified due 
to oxidation, however, are capable of forming fibrils, as 
they undergo a structural change. These monomers 
and oligomers go from a -helix or random coil 
conformation to a -pleated sheet conformation. Sheets 
are then capable of assembling into protofibrils and 
eventually fibrils. Both nitrative and oxidative 
modifications resulting in cross-links cans stabilize the 
filaments, which can then aggregate with other 
intracellular proteins to form aggregates. 
Further examination of the modification of -
synuclein upon nitration indicates that nitration leads to 
-synuclein’s formation of a rapidly folded conformation 
of the protein with an increased secondary structure. 
This modification is a critical step in the formation of 
fibrils, as a non-modified protein does not have the 
ability to fibrillate. 
 
Lipid Binding  
 
Nitration has been found to modify -synuclein’s 
structure and aggregate formation. Recent studies also 
implicate nitration as the cause of diminished lipid 
binding to vesicles. This is important because the 
interaction of -synuclein with lipid vesicles is believed 
to be critical in the regulation of neurotransmission at 
presynaptic terminals. Examination of the protein in the 
presence of lipid vesicles shows that purified monomer-
nitrated -synuclein did bind to lipid vesicles at a 
diminished rate.  
Furthermore, association of -synuclein with 
biological membranes protects the protein from 
oxidation and nitration, thereby decreasing the 
formation of molecules able to form aggregates.  
 
Summary: Effects of -synuclein modification  
 
Several studies have focused on examining Lewy 
bodies. PD aggregates are phosphorylated at several 
resides; however, ser-129 is the major phosphorylation 
site of -synuclein in Lewy bodies (Fujiwara et al., 
2002). CK1, CK2 and Gprk2 and Src protein-tyrosine 
kinase family members phosphorylate the protein in 
vitro (Chen et al., 2005; Ellis et al., 2001; Okochi et al., 
2000). The interaction between -synuclein and 
another protein synphilin-1 is critical to aggregate 
formation and is phosphorylation dependent (Lee et al., 
2005). The question of which protein’s phosphorylation 
is crucial to this aggregation is still under debate (Lee et 
al., 2004; Smith et al., 2005) 
Nitrated -synuclein has also been shown to 
be a major component of Lewy bodies. The protein is 
nitrated at tyrosine 39, as well as tyrosine 125, 133, and 
136. Tyrosine-125 though, appears to have a critical 
role in -synuclein dimerization, as a lack of this 
residue significantly decreases dimerization compared 
to -synuclein lacking tyrosine 39, 133 or 136 (Souza et 
al.,2000).  
-synuclein has been found to be modified as 
a result of nitration and phosphorylation.  Modifications 
include the change in conformation seen in the protein, 
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which allows it to aggregate more readily. The nitration 
and phosphorylation of -synuclein result in the 
increased aggregation of the protein (Chen et al., 2005; 
Norris et al., 2003; Smith et al., 2005; Fujiwara et al., 
2002).  
The relation of aggrigation to toxicity has yet 
to be discovered. There are still conflicting studies 
concerning aggregate formation and its correlation to 
toxicity. While some studies suggest that 
phosphorylation of the protein increases aggregate 
formation and increases toxicity (Chen et al, 2000),  
 
Future Research 
 
As previously stated, the link between aggregation and 
toxicity in post-translation mutants is still under debate. 
Post-translational modification, such as phosphorylation 
and nitration, increase the rate of fibrillation and 
aggregate formation of -synuclein. If this increased 
aggregation is linked to diminished toxicity, then 
perhaps these modifications serve a protective 
purpose.  
Moreover, it is necessary to understand if 
there is a relationship between post-translational 
modifications and neurodegeneration, as this 
relationship is not yet fully understood. nitrosylation-
deficient mutants exhibit significant toxicity (Herrera et 
al., 2005).  
 
Conclusion 
 
Parkinson’s disease is the second most common 
neurodegenerative disease in the world, affecting 
millions of people. Extensively phosphorylated and 
nitrated -synuclein has been found in PD aggregates 
known as Lewy Bodies. Recent studies show that these 
post-translational modifications of -synuclein increase 
the rate of fibril formation and increase the rate of 
aggregate formation. Examinations of the role of  
phosphorylation and nitration on toxicity have not come 
to conclusive results, therefore, future research is 
necessary to understand these post-translational 
modifications’ role in neurodegeneration.  
Research has shed light on the effects of 
phosphorylation and nitration of -synuclein on this 
protein’s aggregation and misfolding, providing 
important evidence of this protein’s role in the 
pathogenesis of PD. 
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